BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.87
-0.36 (-4.37%)
Jun 5, 2026, 1:38 PM EDT - Market open
BBOT Market Cap
BBOT has a market cap or net worth of $630.44 million as of June 5, 2026. Its market cap has increased by 147.16% in one year.
Market Cap
630.44M
Enterprise Value
251.00M
1-Year Change
147.16%
Ranking
Category
Stock Price
$7.87
Market Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $630.44M, an increase of 1,549.83%. That is a compound annual growth rate of 235.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 659.28M | -34.17% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 690.31M |
| Solid Biosciences | 674.38M |
| Relmada Therapeutics | 663.96M |
| Alto Neuroscience | 660.74M |
| Design Therapeutics | 652.05M |
| Zevra Therapeutics | 647.90M |
| CorMedix | 645.66M |
| Candel Therapeutics | 644.78M |